(IBHF) iShares iBonds 2026 Term - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E5289 • Target Maturity

IBHF: High Yield Bonds, Corporate Bonds

The iShares iBonds 2026 Term High Yield and Income ETF (IBHF) is designed to track the performance of an index composed of U.S. dollar-denominated, taxable, fixed-rate corporate bonds. These bonds are categorized as high yield (below investment-grade) or BBB-rated, and are scheduled to mature between January 1, 2026, and December 15, 2026. By focusing on a specific maturity range, the ETF offers exposure to bonds that are set to mature around the same time, providing investors with a predictable income stream as the bonds approach maturity. The fund is non-diversified, meaning it can concentrate its holdings in a smaller number of securities, which may result in higher risk but also potentially higher returns. The ETF trades on the BATS exchange under the ticker symbol IBHF and falls under the Target Maturity category.

As of the latest data, the ETF manages approximately $766.44 million in assets under management (AUM). This scale indicates a moderate-sized fund, which can provide liquidity for investors while maintaining exposure to a targeted segment of the high yield and investment-grade corporate bond market. The funds structure allows it to capture the yield potential of bonds maturing in 2026, making it an option for investors seeking predictable returns as interest rates fluctuate.

Looking ahead, the ETFs performance will likely be influenced by the interest rate environment and credit conditions leading up to 2026. With its focus on shorter-dated high yield bonds, the fund may offer a balance between yield and reduced exposure to interest rate volatility. However, the credit risk associated with high yield bonds remains a consideration. As the bonds approach maturity, the funds portfolio will naturally shift towards shorter durations, potentially appealing to investors seeking to manage interest rate risk in a rising rate environment. Additionally, the predictable maturity schedule can provide clarity for investors looking to align their investments with specific financial goals or time horizons.

Additional Sources for IBHF ETF

IBHF ETF Overview

Market Cap in USD 795m
Category Target Maturity
TER 0.35%
IPO / Inception 2020-11-10

IBHF ETF Ratings

Growth 5y 56.6%
Fundamental -
Dividend 77.0%
Rel. Strength Industry -0.05
Analysts -
Fair Price Momentum 23.34 USD
Fair Price DCF -

IBHF Dividends

Dividend Yield 12m 6.61%
Yield on Cost 5y 7.91%
Annual Growth 5y 60.49%
Payout Consistency 82.3%

IBHF Growth Ratios

Growth Correlation 3m 92.8%
Growth Correlation 12m 99.4%
Growth Correlation 5y 64.1%
CAGR 5y 4.60%
CAGR/Max DD 5y 0.41
Sharpe Ratio 12m 2.52
Alpha 3.62
Beta 0.09
Volatility 2.61%
Current Volume 288.4k
Average Volume 20d 288.8k
What is the price of IBHF stocks?
As of March 14, 2025, the stock is trading at USD 23.13 with a total of 288,400 shares traded.
Over the past week, the price has changed by -0.37%, over one month by -0.43%, over three months by +1.11% and over the past year by +8.19%.
Is iShares iBonds 2026 Term a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares iBonds 2026 Term (BATS:IBHF) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.64 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBHF as of March 2025 is 23.34. This means that IBHF is currently overvalued and has a potential downside of 0.91%.
Is IBHF a buy, sell or hold?
iShares iBonds 2026 Term has no consensus analysts rating.
What are the forecast for IBHF stock price target?
According to ValueRays Forecast Model, IBHF iShares iBonds 2026 Term will be worth about 25.2 in March 2026. The stock is currently trading at 23.13. This means that the stock has a potential upside of +8.99%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 25.2 9%